Senna-S Softgel

Product NDC
84324-030
11-digit product format
843240030
Labeler code
84324
Product ID
84324-030_733d1bb6-dc55-4ca4-96f8-6c418b0b5ea8
Type
HUMAN OTC DRUG
Nonproprietary name
Sennosides 8.6 mg and Docusate Sodium 50 mg
Dosage form
CAPSULE, LIQUID FILLED
Route
ORAL
Labeler
NUVICARE LLC
Application
505G(a)(3)
Marketing category
OTC MONOGRAPH DRUG
Marketing start
2025-06-24
Substance
DOCUSATE SODIUM; SENNOSIDES
Active strength
50; 8.6 mg/1; mg/1
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Senna-S Softgel
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
DOCUSATE SODIUM50 mg/1
SENNOSIDES8.6 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiF05Q2T2JA0, 3FYP5M0IJX
Rxcui1791612

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84324-030-01Senna-S Softgel60 in 1 BOTTLECAPSULE, LIQUID FILLED601

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1791612sennosides 8.6 MG / docusate sodium 50 MG Oral CapsulePSN65a1cce7-984f-490a-bd68-fea97733a72f1
1791612docusate sodium 50 MG / sennosides, USP 8.6 MG Oral CapsuleSCD65a1cce7-984f-490a-bd68-fea97733a72f1
1791612DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral CapsuleSY65a1cce7-984f-490a-bd68-fea97733a72f1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
84324-030-018432400300160 CAPSULE, LIQUID FILLED in 1 BOTTLE (84324-030-01) 2025-06-24NoNoCurrent